13.07.2013 Views

96. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V ...

96. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V ...

96. Jahrestagung der Deutschen Gesellschaft für Pathologie e. V ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

dissection (MBLND) technique to improve the LN staging in gastrointestinal<br />

cancers. Moreover, we combined this technique with an ex-vivo<br />

sentinel mapping method to further improve the staging.<br />

Methods. The technique has been established in pilot studies and than<br />

confirmed in prospective and randomized studies. The injections were<br />

performed in fresh state. Subserosal or submucosal injection of black ink<br />

was performed for the sentinel mapping. Methylene blue (MB) solution<br />

was injected afterwards into the main arteries.<br />

Results. LN harvest was highly significant improved in the MB groups<br />

in comparison to the control groups (colon cancer: 35±18 vs. 17±10; rectal<br />

cancer: 30±14 vs. 17±11). MB technique ensured sufficient LN harvest in<br />

almost all cases including cases of neoadjuvantly treated rectal cancer.<br />

The evSLN detection rate, sensitivity and accuracy in gastric cancer were<br />

87%, 81% and 93%, respectively. Isolated tumor cells were detected after<br />

immunohistochemical staining in 3 of 17 cases (18%). The chance to detect<br />

a metastasis in an evSLN was 2 times higher in comparison to conventional<br />

LNs. In 8% of all cases only evSLN were affected by metastases.<br />

Conclusions. MBLND is a highly effective method of improving the LN<br />

harvest in gastric cancer. Further application of evSLN mapping is feasible<br />

and has the potential to heighten the sensitivity of metastasis detection.<br />

SA-004<br />

EBV-assoziierte Tumoren in Interaktion mit dem Immunsystem<br />

M . Büttner1 1University Hospital Erlangen, Institute of Pathology, Erlangen<br />

Aims. EBV-associated tumours are characterized by a prominent inflammatory<br />

infiltrate, which, however, is not able to eliminate the tumour<br />

cells. Viral proteins like latent membrane protein 1 (LMP1) can interact<br />

with intracellular signalling pathways and thereby modulate the immune<br />

reaction. In or<strong>der</strong> to better un<strong>der</strong>stand immunological processes in<br />

EBV-associated tumours different mechanisms were investigated.<br />

Methods. Paraffin embedded material of classical Hodgkin lymphomas<br />

(cHL), nasopharyngeal carcinomas (NPC) and gastric carcinomas was<br />

investigated by immunohistochemistry and in situ hybridization with<br />

regard to the expression of EBV-encoded and cellular genes, which are<br />

involved in the regulation of the immune reaction. Cell culture experiments<br />

were performed for a better un<strong>der</strong>standing of the mechanisms<br />

involved on cellular basis.<br />

Results. Hodgkin-Reed-Sternberg (HRS) cells of cHL are B cell <strong>der</strong>ivates<br />

with a phenotype which is neither typical for a germinal center B-cell<br />

nor of a plasma cell, but rather reminds of an abortive plasma cell phenotype.<br />

STAT3 a transcription factor with a central role in the linkage of<br />

inflammation and tumorigenesis is expressed in cHL and NPC. LMP1<br />

can induce the chemokines RANTES and MCP-1 in an at least partially<br />

NFkappaB- dependent manner. However, those chemokines are predominantly<br />

expressed in the inflammatory infiltrate rather than the tumour<br />

cells. In EBV-associated cardiac carcinoma an increased number<br />

of cytotoxic T cells is found, which might be a sign of an on-going antiviral<br />

response.<br />

Conclusions. In EBV-associated tumours a complex interaction of cellular<br />

and viral factors takes place, which can modulate the intratumoural<br />

immune reaction. A better un<strong>der</strong>standing of those processes could help<br />

to find potential immune evasive mechanisms applied by the tumours,<br />

which could interfere with an effective immunotherapy.<br />

Aktuelle Entwicklungen in <strong>der</strong> Forschung II –<br />

Gastrointestinaltrakt<br />

SO-001<br />

TNF induces STAT3-mediated inflammation in normal colon<br />

epithelial cells<br />

S . Chakilam1 , A . Agaimy1 , R . Atreya 2 , M . Gandesiri1 , J . Ivanovska1 , M . Rave-<br />

Fränk 3 , H . Christiansen3 , T .T . Rau1 , R . Schnei<strong>der</strong>-Stock 1<br />

1University of Erlangen-Nuremberg, Institute of Pathology, Erlangen,<br />

2University of Erlangen-Nuremberg, Department of Medicine I, Erlangen,<br />

3University Göttingen, Department of Radiation Oncology<br />

Aims. Tumor necrosis factor α (TNF) is a pleiotropic cytokine that participates<br />

in a wide range of biological activities, including inflammation,<br />

growth, differentiation, and apoptosis. TNF is a key molecule in the cytokine<br />

network, capable of regulating the expression of other cytokines,<br />

such as IL-6 which is known to be a major mediator of inflammation<br />

through the activation of the STAT-3 pathway. To simulate the effects of<br />

TNF to normal intestine we treated immortalized human colon epithelial<br />

cells (HCEC) with 0.66 ng/ml TNF and analyzed the possible TNFmediated<br />

functions and signal transduction.<br />

Methods. HCEC cells were stimulated for various time points (1, 6, 24,<br />

48 and 72 h). Activation of transcription factors (NF-kB, ATF-2, and<br />

STAT3) was assessed by western blotting. Inflammation was detected by<br />

real-time RT-PCR and cytokine ELISA. Transcriptional transactivation<br />

was measured by EMSA and chromatin immunoprecipitation. Apoptosis<br />

was analyzed by Annexin V binding assay and M30 staining.<br />

Results. TNF-induced a biphasic pattern of activation of transcription<br />

factors NF-kB, ATF-2, and STAT3 with NF-κB and ATF-2 phosphorylation<br />

at 1 and 6 h, whereas STAT3 activation (pSTAT3Tyr705) and transcriptional<br />

activity was induced later at 48 h. TNF also induced secretion<br />

of the pro-inflammatory cytokines IL-6 and IL-8. We assumed that<br />

the released IL-6 at early time points causes STAT3 activation. Indeed,<br />

IL-6 neutralisation significantly attenuated TNF-induced STAT3 phosphorylation.<br />

Moreover, AG490 (JAK inhibitor) pre-treatment decreased<br />

TNF-induced STAT3 activation and significantly decreased TNF-augmented<br />

IL-6 secretion. As expected, IL-6 stimulation alone also increased<br />

pSTAT3Tyr705 levels. In parallel, there was no remarkable apoptosis<br />

induction despite an increase in DNA-damage measured by pH2AX foci<br />

formation. STAT3 signaling was verified in human tissues from ulcerative<br />

colitis patients.<br />

Conclusions. These data indicate that HCEC cells seem to develop an<br />

inflammatory phenotype upon TNF stress. The TNF-induced inflammation<br />

is regulated by IL-6 and STAT3. We hypothesize that the normal<br />

mucosa is also actively participating in the development and maintenance<br />

of inflammatory conditions in the gut.<br />

SO-002<br />

Establishment of a cell culture model to study inflammationassociated<br />

oxidative stress as initiator of colorectal neoplasias<br />

A . Poehlmann1 , K . Reissig1 , P . Schoenfeld2 , P . Steinberg3 , T . Guenther1 ,<br />

A . Roessner1 1Otto-von-Guericke University Magdeburg, Department of Pathology,<br />

Magdeburg, 2Otto-von-Guericke University Magdeburg, Department of<br />

Biochemistry and Cell Biology, Magdeburg, 3Institut of Food Toxicology and<br />

Analytical Chemistry, Hannover<br />

Aims. Accumulating evidence shows that oxidative stress displayed by<br />

reactive oxygen species (ROS) is a major contributor to inflammationassociated<br />

cancer. Whether oxidative stress in inflammatory bowel disease<br />

(IBD)-associated carcinogenesis is only a promoting factor or linked<br />

to tumor initiation is still an open question. To find evidence for the<br />

transforming capacity and tumor-initiation effects of ROS, we generated<br />

Der Pathologe · Supplement 1 · 2012 |<br />

59

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!